All News
U.S. Deaths Are Down and Life Expectancy Is Up, but Improvements Are Slowing
(MedPage Today) -- U.S. life expectancy jumped last year, and preliminary data suggest there may be another -- much smaller -- improvement this year.
Read MoreA Letter to Healthcare Leaders on 'Transforming' the System
(MedPage Today) -- In any industry, there's a boundary of performance for which the operational state-of-the-art is attained. This is a place of maximum convergence and hyper-commoditization.
Read MoreEx-Wife of Ambushed Doc Arrested; Gender-Affirming Care Suit; COVID Testing Scheme
(MedPage Today) -- The ex-wife of a Los Angeles doctor who was murdered in an ambush outside his office has been arrested for the crime along with four other suspects.
Read MoreSTAT+: The health care deal is in jeopardy
House Speaker Mike Johnson faced a conservative rebellion stoked by Elon Musk and Donald Trump, pushing the U.S. toward a shut down.
Read MoreMail-Order Stool Testing for IBD Favorable to Patients
(MedPage Today) -- Patients with inflammatory bowel disease (IBD) reported mostly favorable responses with the use of mail-order kits for stool sample collections, according to a survey study.
Read MoreVedolizumab Edges Out Infliximab for Ulcerative Colitis in Real-World Study
(MedPage Today) -- ORLANDO -- Vedolizumab (Entyvio) and infliximab (Remicade) led to mostly similar 1-year outcomes in patients with ulcerative colitis previously untreated with a biologic, but the
Read MoreSTAT+: FDA confirms tirzepatide shortage is still over, gives compounders a grace period
The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put a stop to companies making cheaper copies.
Read MoreSTAT+: Pharmalittle: We’re reading about a Vertex pain drug, the Feds suing CVS over opioids, and more
Vertex's closely watched drug, suzetrigine, reduced sciatica pain compared to baseline but did not outperform a placebo
Read MoreSerious Catheter Recall; Justice Department Sues CVS; 2025's Health Theme
(MedPage Today) -- Note that some links may require registration or subscription.
Read MoreBiotech stocks hammered after Fed rate projections
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. This is my last newsletter this year.
Read More